Evercore ISI Begins Coverage on Repligen (NASDAQ:RGEN)
Equities researchers at Evercore ISI started coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a report released on Tuesday, Marketbeat Ratings reports. The firm set an “in-line” rating and a $155.00 price target on the biotechnology company’s stock. Evercore ISI’s price objective points to a potential upside of 6.99% from the company’s […]
Equities researchers at Evercore ISI started coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a report released on Tuesday, Marketbeat Ratings reports. The firm set an “in-line” rating and a $155.00 price target on the biotechnology company’s stock. Evercore ISI’s price objective points to a potential upside of 6.99% from the company’s […]
